Aandeel A144510 GC CELL CORPORATION
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen GC Cell Corporation

Aandelen

A144510

KR7144510005

slotkoers Korea S.E.
Andere beurzen
 00:00:00 18-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
36.650 KRW +2,52% Intraday-grafiek van GC Cell Corporation -2,53% -19,45%
26/02 GC Cell en Biocentriq® sluiten overeenkomst voor procesoverdracht in afwachting van de introductie in de VS van Immuncell-LC Inj CI
08/01 GC Cell's veelbelovende AB-201 kankerbehandeling begint aan fase 1 onderzoek met Lunit AI platform CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
GC Cell and Biocentriq® Execute Process Transfer Agreement in Anticipation of the U.S. Entry of Immuncell-LC Inj
GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform
GC Cell Affiliate BioCentriq Secures $29 Million in Funding Round
GC Cell Signs Agreement with Lunit for AI-Powered Cancer Treatment
GC Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
GC Cell Obtains Anti-Bribery Management System Certification from Korea Compliance Initiative
GC Cell Inks First Licensing Agreement for Immuncell-LC® With Rivaara Immune Private Limited in India
Green Cross Lab Cell Corporation completed the acquisition of Green Cross Cell Corporation from a group of shareholders.
Green Cross Lab Cell Corporation entered into a definitive merger agreement to acquire Green Cross Cell Corporation from a group of shareholders for approximately KRW 510 billion.
Artiva Biotherapeutics, Inc. announced that it has received $120.000001 million in funding from a group of investors
Artiva Biotherapeutics, Inc. announced that it expects to receive $120.000001 million in funding
Artiva Biotherapeutics, Inc. announced that it expects to receive $80.552315 million in funding from 5AM Venture Management, LLC, venBio LLC, RA Capital Management, L.P., Medivate Partners LLC, Green Cross Holdings Corporation, Green Cross Lab Cell Corporation
Kleo Pharmaceuticals Enters into Research Collaboration with Green Cross LabCell to Rapidly Develop COVID-19-Targeting Allogeneic NK Cell Combination Therapy
Green Cross LabCell and Feldan Therapeutics Announce a Joint Research Collaboration to Develop Low Immunogenicity, High-Performance Natural Killer Anticancer Treatment
Green Cross Lab Cell Corporation Announces Executive Changes
Green Cross Lab Cell Corporation(KOSDAQ:A144510) added to S&P Global BMI Index
GreenCross LabCell Corporation has completed an IPO in the amount of KRW 37.00 billion.
Oxford BioMedica plc Enters into Research & Development Collaboration with Green Cross LabCell
GreenCross LabCell Corporation has filed an IPO.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A144510
  4. Nieuws GC Cell Corporation
  5. Andere talen